Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
NCT02676843
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Frontotemporal Lobar Degeneration (FTLD)
Frontotemporal Dementia (FTD)
Tauopathies
Interventions
DRUG:
18F-AV-1451
Sponsor
Columbia University
Collaborators
[object Object]